Grey Matters Health Raises $1.1M in Expanded Private Placement — Grey Matters Health Inc.

Event summary

Grey Matters Health increased its private placement offering from CAD $800,000 to CAD $1.1 million, adding a second tranche of CAD $500,000.
First tranche closed on September 10, 2026, raising CAD $600,000 from 712,500 equity units and debenture units.
Proceeds will fund Alzheimer’s Disease program, U.S. brain-specific neuroimaging clinic, and working capital.
Second tranche expected to close by September 21, 2026, with securities subject to a four-month hold period.

The big picture

Grey Matters Health’s expanded private placement reflects growing investor interest in neuroimaging technologies for early-stage Alzheimer’s detection. The CAD $1.1 million raise underscores the strategic importance of scaling its U.S. clinic network amid increasing demand for specialized brain health diagnostics. The company’s ability to execute on its clinical and operational goals will be critical in differentiating itself in a crowded healthcare innovation landscape.

What we're watching

Funding Execution: Whether Grey Matters can close the second tranche by September 21, 2026, and meet its CAD $1.1 million target.
Clinical Progress: The pace at which the company advances its Alzheimer’s Disease program and opens the U.S. neuroimaging clinic.
Market Positioning: How the expanded funding will position Grey Matters in the competitive neuroimaging and neurodegenerative disease detection space.